AZTA
HealthcareAzenta, Inc.
$21.43+0.06 (+0.28%)
Prev Close
$21.37
Open
$21.70
High
$21.99
Low
$21.32
Volume
624.7K
Market Cap
$1.07B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Azenta, Inc. (AZTA) has been dominated by selling, with 1 insider purchase totaling $69.9K and 7 insider sales totaling $567.8K. The most recent insider transaction was by Lin Lawrence Y. (EVP, CFO and Treasurer), who sold $90.4K worth of shares on Nov 14, 2025. Azenta, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $1.07B.
Buys (12M)
1
$69.9K
Sells (12M)
7
$567.8K
Net Activity
Net Seller
$497.9K
Active Insiders
5
last 12 mo
AZTA Price Chart
AZTA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025↗ | Lin Lawrence Y. | EVP, CFO and Treasurer | Sell | 3,039 | $29.75 | $90.4K | 0 |
| Nov 14, 2025↗ | Marotta John | President and CEO | Sell | 10,980 | $29.75 | $326.7K | 0 |
| Nov 14, 2025↗ | Pirogova Olga | SVP and CHRO | Sell | 1,553 | $29.75 | $46.2K | 0 |
| Nov 14, 2025↗ | Zhou Ginger | SVP and GM, Multiomics | Sell | 1,118 | $29.75 | $33.3K | 0 |
| Sep 9, 2025↗ | Marotta John | President and CEO | Sell | 316 | $29.41 | $9.3K | 0 |
| Aug 12, 2025↗ | Pirogova Olga | SVP and CHRO | Sell | 1,085 | $28.54 | $31.0K | 0 |
| Aug 12, 2025↗ | Zhou Ginger | SVP and GM, Multiomics | Sell | 1,085 | $28.54 | $31.0K | 0 |
| Aug 11, 2025↗ | Lin Lawrence Y. | EVP, CFO and Treasurer | Buy | 2,500 | $27.96 | $69.9K | 0 |
| Feb 3, 2025↗ | Hughes Violetta | VP, Chief Accounting Officer | Sell | 317 | $52.97 | $16.8K | 0 |
| Jan 31, 2025↗ | Zhou Ginger | SVP and General Manager, Genom | Buy | 417 | $45.88 | $19.1K | 0 |
| Dec 4, 2024↗ | Wang David Dong | SVP & GM, SMS | Sell | 140 | $46.65 | $6.5K | 0 |
| Nov 19, 2024↗ | Cueto Herman | EVP, Chief Financial Officer | Sell | 712 | $40.07 | $28.5K | 0 |
| Nov 19, 2024↗ | Hughes Violetta | VP, Chief Accounting Officer | Sell | 163 | $40.07 | $6.5K | 0 |
| Nov 19, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,139 | $40.07 | $45.6K | 0 |
| Nov 19, 2024↗ | Madaus Martin D | Director | Buy | 4,940 | $40.77 | $201.4K | 0 |
| Nov 19, 2024↗ | Pirogova Olga | SVP and CHRO | Sell | 548 | $40.07 | $22.0K | 0 |
| Nov 19, 2024↗ | Wang David Dong | SVP & GM, SMS | Sell | 348 | $40.07 | $13.9K | 0 |
| Nov 19, 2024↗ | Zhou Ginger | SVP and General Manager, Genom | Sell | 491 | $40.07 | $19.7K | 0 |
| Nov 18, 2024↗ | Cornog William L | Director | Buy | 12,500 | $39.60 | $495.0K | 0 |
| Nov 18, 2024↗ | HIRSCH DIDIER | Director | Buy | 1,000 | $39.50 | $39.5K | 0 |
| Nov 15, 2024↗ | Marotta John | President and CEO | Buy | 13,967 | $39.59 | $552.9K | 0 |
| Nov 6, 2024↗ | Cornog William L | Director | Sell | 995 | $46.52 | $46.3K | 0 |
| Nov 6, 2024↗ | Malus Alan J | Director | Sell | 995 | $46.52 | $46.3K | 0 |
| Oct 17, 2024↗ | Cueto Herman | EVP, Chief Financial Officer | Sell | 1,595 | $43.68 | $69.7K | 0 |
| Aug 1, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,000 | $62.05 | $62.0K | 0 |
| Jul 25, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 3,000 | $60.00 | $180.0K | 0 |
| May 20, 2024↗ | Hughes Violetta | VP, Chief Accounting Officer | Sell | 584 | $51.36 | $30.0K | 0 |
| Apr 1, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,000 | $60.15 | $60.1K | 0 |
| Mar 7, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 13,000 | $65.85 | $856.0K | 0 |
| Dec 5, 2023↗ | Vacha Robin | SVP, GM Life Science Products | Sell | 5,175 | $56.60 | $292.9K | 0 |
| Dec 1, 2023↗ | Wang David Dong | SVP & GM, SMS | Sell | 138 | $57.96 | $8.0K | 0 |
| Nov 17, 2023↗ | Gray David C | Chief Strategy & New Business | Sell | 5,179 | $54.83 | $284.0K | 0 |
| Nov 15, 2023↗ | Gray David C | Chief Strategy & New Business | Sell | 2,161 | $53.81 | $116.3K | 0 |
| Nov 15, 2023↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,831 | $53.81 | $98.5K | 0 |
| Nov 15, 2023↗ | Robertson Lindon G | EVP & Chief Financial Officer | Sell | 2,779 | $53.81 | $149.5K | 0 |
| Nov 15, 2023↗ | SCHWARTZ STEPHEN S | CEO | Sell | 12,865 | $53.81 | $692.3K | 0 |
| Nov 15, 2023↗ | Vacha Robin | SVP, GM Life Science Products | Sell | 2,946 | $53.81 | $158.5K | 0 |
| Nov 15, 2023↗ | Zhou Ginger | SVP and General Manager, Genom | Sell | 458 | $53.81 | $24.6K | 0 |
| Aug 10, 2023↗ | Gray David C | Chief Strategy & New Business | Sell | 15,188 | $56.37 | $856.2K | 0 |
| Jun 6, 2023↗ | MARTIN JOSEPH R | Director | Sell | 2,400 | $43.07 | $103.4K | 0 |
| Aug 19, 2022↗ | McManus Matthew | EVP & Chief Operating Officer | Buy | 8,625 | $58.15 | $501.5K | 0 |
| Aug 19, 2022↗ | Robertson Lindon G | EVP & Chief Financial Officer | Buy | 4,350 | $57.62 | $250.6K | 0 |
| Apr 12, 2022↗ | Crowley Kimberly | SVP, Chief HR Officer | Sell | 132 | $78.02 | $10.3K | 0 |
| Jan 4, 2022↗ | De Jesus Linda | Chief Commercial Officer, LS | Sell | 191 | $102.59 | $19.6K | 0 |
| Nov 19, 2021↗ | Jarzynka David | President, Semi Solutions | Sell | 10,216 | $120.29 | $1.23M | 0 |
| Nov 17, 2021↗ | Gray David C | Chief Strategy & New Business | Sell | 11,451 | $118.99 | $1.36M | 0 |
| Nov 17, 2021↗ | Jarzynka David | President, Semi Solutions | Sell | 13,100 | $119.27 | $1.56M | 0 |
| Nov 17, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 8,694 | $119.27 | $1.04M | 0 |
| Nov 17, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 4,830 | $119.27 | $576.1K | 0 |
| Nov 17, 2021↗ | Robertson Lindon G | EVP & Chief Financial Officer | Sell | 18,331 | $119.27 | $2.19M | 0 |
| Nov 17, 2021↗ | SCHWARTZ STEPHEN S | CEO | Sell | 41,351 | $119.27 | $4.93M | 0 |
| Nov 17, 2021↗ | Vacha Robin | SVP, GM BLS-Products | Sell | 15,368 | $119.17 | $1.83M | 0 |
| Nov 12, 2021↗ | Rosenblatt Michael | Director | Sell | 2,831 | $114.13 | $323.1K | 0 |
| Sep 27, 2021↗ | Montone William T. | SVP, Human Resources | Sell | 4,140 | $110.00 | $455.4K | 0 |
| Sep 22, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 2,500 | $105.00 | $262.5K | 0 |
| Sep 20, 2021↗ | Montone William T. | SVP, Human Resources | Sell | 4,140 | $104.00 | $430.6K | 0 |
| Sep 20, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 12,500 | $100.00 | $1.25M | 0 |
| Sep 7, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $90.00 | $96.4K | 0 |
| Jul 21, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $90.00 | $96.4K | 0 |
| Jun 28, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $98.00 | $105.0K | 0 |
| Jun 28, 2021↗ | Montone William T. | SVP, Human Resources | Sell | 4,139 | $98.00 | $405.6K | 0 |
| Jun 24, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $95.00 | $101.7K | 0 |
| Jun 24, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 2,000 | $95.00 | $190.0K | 0 |
| Jun 24, 2021↗ | SCHWARTZ STEPHEN S | CEO | Sell | 19,500 | $95.00 | $1.85M | 0 |
| Jun 21, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $91.78 | $98.3K | 0 |
| Jun 18, 2021↗ | SCHWARTZ STEPHEN S | CEO | Sell | 25,500 | $91.97 | $2.35M | 0 |
| May 13, 2021↗ | Rosenblatt Michael | Director | Sell | 1,760 | $90.00 | $158.4K | 0 |
AZTA Insider Buying Activity
The following table shows recent insider purchases of Azenta, Inc. (AZTA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025↗ | Lin Lawrence Y. | EVP, CFO and Treasurer | Buy | 2,500 | $27.96 | $69.9K | 0 |
| Jan 31, 2025↗ | Zhou Ginger | SVP and General Manager, Genom | Buy | 417 | $45.88 | $19.1K | 0 |
| Nov 19, 2024↗ | Madaus Martin D | Director | Buy | 4,940 | $40.77 | $201.4K | 0 |
| Nov 18, 2024↗ | Cornog William L | Director | Buy | 12,500 | $39.60 | $495.0K | 0 |
| Nov 18, 2024↗ | HIRSCH DIDIER | Director | Buy | 1,000 | $39.50 | $39.5K | 0 |
| Nov 15, 2024↗ | Marotta John | President and CEO | Buy | 13,967 | $39.59 | $552.9K | 0 |
| Aug 19, 2022↗ | McManus Matthew | EVP & Chief Operating Officer | Buy | 8,625 | $58.15 | $501.5K | 0 |
| Aug 19, 2022↗ | Robertson Lindon G | EVP & Chief Financial Officer | Buy | 4,350 | $57.62 | $250.6K | 0 |
AZTA Insider Selling Activity
The following table shows recent insider sales of Azenta, Inc. (AZTA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025↗ | Lin Lawrence Y. | EVP, CFO and Treasurer | Sell | 3,039 | $29.75 | $90.4K | 0 |
| Nov 14, 2025↗ | Marotta John | President and CEO | Sell | 10,980 | $29.75 | $326.7K | 0 |
| Nov 14, 2025↗ | Pirogova Olga | SVP and CHRO | Sell | 1,553 | $29.75 | $46.2K | 0 |
| Nov 14, 2025↗ | Zhou Ginger | SVP and GM, Multiomics | Sell | 1,118 | $29.75 | $33.3K | 0 |
| Sep 9, 2025↗ | Marotta John | President and CEO | Sell | 316 | $29.41 | $9.3K | 0 |
| Aug 12, 2025↗ | Pirogova Olga | SVP and CHRO | Sell | 1,085 | $28.54 | $31.0K | 0 |
| Aug 12, 2025↗ | Zhou Ginger | SVP and GM, Multiomics | Sell | 1,085 | $28.54 | $31.0K | 0 |
| Feb 3, 2025↗ | Hughes Violetta | VP, Chief Accounting Officer | Sell | 317 | $52.97 | $16.8K | 0 |
| Dec 4, 2024↗ | Wang David Dong | SVP & GM, SMS | Sell | 140 | $46.65 | $6.5K | 0 |
| Nov 19, 2024↗ | Cueto Herman | EVP, Chief Financial Officer | Sell | 712 | $40.07 | $28.5K | 0 |
| Nov 19, 2024↗ | Hughes Violetta | VP, Chief Accounting Officer | Sell | 163 | $40.07 | $6.5K | 0 |
| Nov 19, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,139 | $40.07 | $45.6K | 0 |
| Nov 19, 2024↗ | Pirogova Olga | SVP and CHRO | Sell | 548 | $40.07 | $22.0K | 0 |
| Nov 19, 2024↗ | Wang David Dong | SVP & GM, SMS | Sell | 348 | $40.07 | $13.9K | 0 |
| Nov 19, 2024↗ | Zhou Ginger | SVP and General Manager, Genom | Sell | 491 | $40.07 | $19.7K | 0 |
| Nov 6, 2024↗ | Cornog William L | Director | Sell | 995 | $46.52 | $46.3K | 0 |
| Nov 6, 2024↗ | Malus Alan J | Director | Sell | 995 | $46.52 | $46.3K | 0 |
| Oct 17, 2024↗ | Cueto Herman | EVP, Chief Financial Officer | Sell | 1,595 | $43.68 | $69.7K | 0 |
| Aug 1, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,000 | $62.05 | $62.0K | 0 |
| Jul 25, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 3,000 | $60.00 | $180.0K | 0 |
| May 20, 2024↗ | Hughes Violetta | VP, Chief Accounting Officer | Sell | 584 | $51.36 | $30.0K | 0 |
| Apr 1, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,000 | $60.15 | $60.1K | 0 |
| Mar 7, 2024↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 13,000 | $65.85 | $856.0K | 0 |
| Dec 5, 2023↗ | Vacha Robin | SVP, GM Life Science Products | Sell | 5,175 | $56.60 | $292.9K | 0 |
| Dec 1, 2023↗ | Wang David Dong | SVP & GM, SMS | Sell | 138 | $57.96 | $8.0K | 0 |
| Nov 17, 2023↗ | Gray David C | Chief Strategy & New Business | Sell | 5,179 | $54.83 | $284.0K | 0 |
| Nov 15, 2023↗ | Gray David C | Chief Strategy & New Business | Sell | 2,161 | $53.81 | $116.3K | 0 |
| Nov 15, 2023↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,831 | $53.81 | $98.5K | 0 |
| Nov 15, 2023↗ | Robertson Lindon G | EVP & Chief Financial Officer | Sell | 2,779 | $53.81 | $149.5K | 0 |
| Nov 15, 2023↗ | SCHWARTZ STEPHEN S | CEO | Sell | 12,865 | $53.81 | $692.3K | 0 |
| Nov 15, 2023↗ | Vacha Robin | SVP, GM Life Science Products | Sell | 2,946 | $53.81 | $158.5K | 0 |
| Nov 15, 2023↗ | Zhou Ginger | SVP and General Manager, Genom | Sell | 458 | $53.81 | $24.6K | 0 |
| Aug 10, 2023↗ | Gray David C | Chief Strategy & New Business | Sell | 15,188 | $56.37 | $856.2K | 0 |
| Jun 6, 2023↗ | MARTIN JOSEPH R | Director | Sell | 2,400 | $43.07 | $103.4K | 0 |
| Apr 12, 2022↗ | Crowley Kimberly | SVP, Chief HR Officer | Sell | 132 | $78.02 | $10.3K | 0 |
| Jan 4, 2022↗ | De Jesus Linda | Chief Commercial Officer, LS | Sell | 191 | $102.59 | $19.6K | 0 |
| Nov 19, 2021↗ | Jarzynka David | President, Semi Solutions | Sell | 10,216 | $120.29 | $1.23M | 0 |
| Nov 17, 2021↗ | Gray David C | Chief Strategy & New Business | Sell | 11,451 | $118.99 | $1.36M | 0 |
| Nov 17, 2021↗ | Jarzynka David | President, Semi Solutions | Sell | 13,100 | $119.27 | $1.56M | 0 |
| Nov 17, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 8,694 | $119.27 | $1.04M | 0 |
| Nov 17, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 4,830 | $119.27 | $576.1K | 0 |
| Nov 17, 2021↗ | Robertson Lindon G | EVP & Chief Financial Officer | Sell | 18,331 | $119.27 | $2.19M | 0 |
| Nov 17, 2021↗ | SCHWARTZ STEPHEN S | CEO | Sell | 41,351 | $119.27 | $4.93M | 0 |
| Nov 17, 2021↗ | Vacha Robin | SVP, GM BLS-Products | Sell | 15,368 | $119.17 | $1.83M | 0 |
| Nov 12, 2021↗ | Rosenblatt Michael | Director | Sell | 2,831 | $114.13 | $323.1K | 0 |
| Sep 27, 2021↗ | Montone William T. | SVP, Human Resources | Sell | 4,140 | $110.00 | $455.4K | 0 |
| Sep 22, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 2,500 | $105.00 | $262.5K | 0 |
| Sep 20, 2021↗ | Montone William T. | SVP, Human Resources | Sell | 4,140 | $104.00 | $430.6K | 0 |
| Sep 20, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 12,500 | $100.00 | $1.25M | 0 |
| Sep 7, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $90.00 | $96.4K | 0 |
| Jul 21, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $90.00 | $96.4K | 0 |
| Jun 28, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $98.00 | $105.0K | 0 |
| Jun 28, 2021↗ | Montone William T. | SVP, Human Resources | Sell | 4,139 | $98.00 | $405.6K | 0 |
| Jun 24, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $95.00 | $101.7K | 0 |
| Jun 24, 2021↗ | Pietrantoni David | Principal Accounting Officer | Sell | 2,000 | $95.00 | $190.0K | 0 |
| Jun 24, 2021↗ | SCHWARTZ STEPHEN S | CEO | Sell | 19,500 | $95.00 | $1.85M | 0 |
| Jun 21, 2021↗ | Joseph Jason | SVP, General Counsel, Secy. | Sell | 1,071 | $91.78 | $98.3K | 0 |
| Jun 18, 2021↗ | SCHWARTZ STEPHEN S | CEO | Sell | 25,500 | $91.97 | $2.35M | 0 |
| May 13, 2021↗ | Rosenblatt Michael | Director | Sell | 1,760 | $90.00 | $158.4K | 0 |
AZTA Insiders
Similar Stocks to AZTA
ISRG
Intuitive Surgical, Inc.
$470.59-1.81%
$170.20B
BDX
Becton, Dickinson and Company
$159.66+0.02%
$57.83B
RMD
ResMed Inc.
$231.35-0.45%
$33.92B
MDLN
Medline Inc.
$41.44+0.90%
$33.33B
WST
West Pharmaceutical Services, Inc.
$235.46+1.82%
$16.96B
HOLX
Hologic, Inc.
$75.12-0.13%
$16.77B
COO
The Cooper Companies, Inc.
$69.92-2.04%
$13.64B
MASI
Masimo Corporation
$175.50+0.00%
$9.42B